✦ LIBER ✦

State of the Art: Targeting the Ubiquitin-Proteasome System for Drug Discovery

✍ Scribed by Sachiko Tsukamoto; Hideyoshi Yokosawa

Publisher: John Wiley and Sons
Year: 2005
Weight: 8 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200514252

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracellular Protein Degradation: From

Intracellular Protein Degradation: From a Vague Idea, Through the Lysosome and the Ubiquitin—Proteasome System, and onto Human Diseases and Drug Targeting (Nobel Lecture)

✍ Aaron Ciechanover 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 2 views

Intracellular Protein Degradation: From

Intracellular Protein Degradation: From a Vague Idea, through the Lysosome and the Ubiquitin–Proteasome System, and onto Human Diseases and Drug Targeting (Nobel Lecture)

✍ Aaron Ciechanover 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

State-of-the-art process for the safe sy

State-of-the-art process for the safe synthesis of anticancer drugs

✍ Vince Ammoscato; Rebecca Wickenheiser; John Henderson; Stephen Munk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

State of the Art Pump Technology for Rev

State of the Art Pump Technology for Reverse Osmosis Systems

✍ R. Schmitz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Chemical Modification of Therapeutic Dru

Chemical Modification of Therapeutic Drugs or Drug Vector Systems to Achieve Targeted Therapy: Looking for the Grail

✍ L. Juillerat-Jeanneret; F. Schmitt 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

Chemical modification of therapeutic dru

Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail

✍ L. Juillerat-Jeanneret; F. Schmitt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract Most therapeutic drugs distribute to the whole body, which results in general toxicity and poor acceptance of the treatments by patients. The targeted delivery of chemotherapeutics to defined cells, either stromal or cancer cells in cancer lesions, or defined inflammatory cells in immun